Search
Ultragenyx Pharmaceutical Inc
RAREAdd to Watchlist
32.870USD
-0.520-1.56%
Market hours （ET）Quotes delayed by 15 min
3.23BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Crysvita royalty revenue
304.00M
45.17%
Crysvita
177.00M
26.30%
Dojolvi
96.00M
14.26%
Evkeeza
59.00M
8.77%
Mepsevii
37.00M
5.50%
By RegionUSD
Name
Revenue
Proportion
North America
377.00M
56.02%
Latin America
170.00M
25.26%
Europe Middle East and Africa
108.00M
16.05%
Asia Pacific
18.00M
2.67%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Crysvita royalty revenue
304.00M
45.17%
Crysvita
177.00M
26.30%
Dojolvi
96.00M
14.26%
Evkeeza
59.00M
8.77%
Mepsevii
37.00M
5.50%